Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Ziopharm Oncology
Ziopharm Oncology
Activities:
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
Johnson & Johnson completes V-Wave acquisition to support patients with heart failure
The strategic acquisition will bolster the pharma giant's MedTech offerings for patients with cardiovascular disease
Aveva World 2024 highlights increasing efficiency with Shiftconnector and AI
Live demo to showcase real-time data and AI-powered troubleshooting
Rousselot
Rousselot is the global leader* of collagen-based solutions for the food, health and nutrition, biomedical and pharmaceutical sectors. Working in partnership with our global...
Merck's MilliporeSigma cuts the ribbon on €290m US biosafety and analytical facility
The site will host biosafety testing, analytical development and cell banking manufacturing services
Hubble Therapeutics selects Andelyn Biosciences to manufacture its AAVs
The CDMO will be responsible for the manufacture of adeno-associated viruses in order to treat leber congenital amaurosis 16
Upcoming event
Lab Innovations
30-31 October 2024 | Exhibition | Birmingham, UK
See all
Related Content
You need to be a subscriber to read this article.
Click here
to find out more.
Research & Development
Homing in on cancer targets
Traditional cancer treatments like chemo- and radiotherapy are blunt instruments. Dr Sarah Houlton looks at developments in CAR T-cell technology, which promises a much more precise approach
Subscribe now